Digital Diabetes Management Market is estimated to be valued at USD 13.97 Bn in 2025 and is expected to reach USD 57.83 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of22.5% from 2025 to 2032.
The global digital diabetes management market is experiencing strong growth owing to the increasing prevalence of diabetes and growing geriatric population around the world. Moreover, the advent of Artificial Intelligence (AI) in diabetes management devices and increasing demand for digital diabetes management devices is expected to boost the growth of the market. However, factors such as high cost of digital diabetes management devices and patient data privacy concerns are expected to hamper growth of the global digital diabetes management market.
|
Current Event |
Description and its Impact |
|
AI and Machine Learning Integration in Healthcare |
|
|
Healthcare Data Privacy Regulations and Cybersecurity Concerns |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
AI is changing the Digital Diabetes Management Market by making it possible to execute predictive analytics, personalized treatment, and pinpoint problems early. AI-powered algorithms examine data from continuous glucose monitoring, lifestyle changes, and medical records to give you real-time information and personalized suggestions.
AI-driven apps, smart insulin delivery systems, and diagnostic platforms for diabetic retinopathy are some of the tools that help patients get more involved and doctors make better decisions. AI is a key part of digital health innovation in 2025 due to the blends machine learning with connected devices to minimize down on hospital visits, improve glycemic control, and support proactive, cost-effective diabetes care.
For instance, in November 2025, At the China International Import Expo, Fangzhou and Novo Nordisk announced a partnership to create AI-powered tools to help people with diabetes and weight loss. The partnership uses AI and digital platforms to improve long-term care, personalized treatment, and patient monitoring. This is a big step forward for AI-powered digital diabetes management in China.
In terms of type, the wearable devices segment is also expected to lead the market with 58.2% share in 2025, owing to the increasing adoption of wearable devices. The wearable devices include continuous glucose monitors and smart insulin pumps. A wearable device provides real-time monitoring, integration with mobile apps, and continuous data collection. The adoption of wearable devices is observed by patient preference for convenience and accuracy, particularly for those requiring constant glucose tracking.
For instance, in December 2025, Medtronic released its MiniMed 780G insulin pump in the U.S. It comes with Abbott's new Instinct continuous glucose monitoring sensor. The system automatically gives insulin every five minutes and has technology that can track glucose levels and find meals in real time. The launch is a big step forward in wearable digital diabetes management because the sensors can be worn for up to 15 days.
In terms of product, the continuous blood glucose monitoring systems segment is expected to dominate the market in 2025, attributed to the increasing awareness among people about diabetes care and the benefits of continuous blood glucose monitoring devices. The CGMs offers with real-time glucose readings, trend analysis, and alert for hypo/hyperglycemia. The continuous blood glucose monitoring system is adopted by both Type 1 and Type 2 diabetes patients, supported by insurance coverage and clinical guidelines.
For instance, in December 2025, Dexcom introduced its new G7 15-Day continuous glucose monitoring system, extending wear time by 50% compared to the previous version. The device offers real-time glucose readings, improved accuracy, and customizable alerts for hypo- and hyperglycemia. Designed for both Type 1 and Type 2 diabetes patients, the G7 integrates seamlessly with apps and smart devices, enhancing digital diabetes management.
To learn more about this report, Download Free Sample
North America is expected to gain highest share of 38.4% share in the market in 2025 due to the increasing prevalence of diabetes, growing geriatric population, rise in adoption of digital diabetes management devices, and growing awareness among people in the region. For instance, according to the Centers for Disease Control and Prevention’s (CDC’s) National Diabetes Statistics Report (2025), over 130 billion adults in the U.S. are living with diabetes or prediabetes. Growing rates of obesity, poor diets, and lack of physical activity, among others, have contributed to a more than three-fold increase in the number of adults living with diabetes.
For instance, in November 2025, UMass Chan Medical School opened a new center to study into how digital tools can help people who take GLP-1 medications. The initiative aims to enhance diabetes and obesity care by integrating digital health tools with drug therapies, improving adherence, monitoring, and outcomes.
Asia Pacific is projected to be the fastest growing region, owing to increasing prevalence of diabetes especially in India and China. This is because healthcare infrastructure is expanding and more people are becoming aware of digital health solutions. The market is growing quickly across the region as more people are using wearable devices, mobile apps, and continuous glucose monitoring systems. This is helped by government programs and low prices.
For instance, in November 2025, QNET India has started a new digital campaign to promote smarter diabetes wellness. Its goal is to raise awareness and encourage people to make healthier choices. The program uses digital platforms to get patients and caregivers involved, showing off new ways to keep an eye on and control diabetes. This campaign shows how important digital solutions are becoming in improving diabetes care across India.
The U.S. digital diabetes management market will be extremely competitive in 2025 considering more and more people are getting diabetes, continuous glucose monitoring systems and smart insulin devices are becoming more popular, and connected health platforms are getting better. The U.S. is the largest marketplace in the world since it has good insurance coverage, good reimbursement policies, and patients' preference for personalized digital care.
For instance, in February 2025, Owens & Minor released ByramConnect, a digital health platform designed to aid people with diabetes and other long-term illnesses. The platform has connected tools, features to get patients involved, and digital support services to help people manage their diseases better. This project, which is based in the United States, strengthens North America's leadership in digital diabetes management by combining technology with patient care.
In 2025, China's digital diabetes management market is expected to be highly profitable due to there are a lot individuals with diabetes, cities are growing quickly, lifestyles are changing, and the government is putting significant resources into digital health infrastructure. More people are using continuous glucose monitoring systems, mobile apps, and AI-driven platforms, which helps patients get better results. Demand is growing even more as people become more aware of it and it becomes more affordable. This makes China a fast-growing center in Asia-Pacific.
For instance, in November 2025, Sinocare showcased its latest digital diabetes solutions at the 2025 Annual Meeting of the Chinese Diabetes Society in Xi’an, China. The iCan continuous glucose monitoring system, hospital-wide glycemic management tools, and out-of-hospital health platforms were some of the best parts. The initiative shows how quickly Asia-Pacific is using digital technologies to improve diabetes care and patient outcomes.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 13.97 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 22.5% | 2032 Value Projection: | USD 57.83 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Abbott Laboratories, Acon Laboratories, Inc., Bayer AG, F. Hoffmann-la Roche Ltd., Johnson and Johnson, Medtronic Plc, Novo Nordisk A/S, Terumo Corporation, Dexcom, Inc., and Becton, Dickinson and Company, among others. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
One of the key factors expected to augment the growth of the global digital diabetes management market over the forecast period is the increasing prevalence of diabetes across the globe. Diabetes is a chronic, and largely preventable, disease that can lead to cardiovascular disease, kidney failure, blindness, loss of limbs, and loss of life. According to the International Diabetes Federation (IDF), around 537 billion people (aged 20 to 79 year) are living with diabetes, and the number is expected to reach around 643 billion by 2030 and 783 billion by 2045. This in turn is expected to increase the adoption of digital diabetes management devices worldwide.
Another factor driving the growth of the global digital diabetes management market is the growing geriatric population around the world. For instance, diabetes is common in older adults, affecting an estimated 33% of people aged 65 and older. Geriatric population is more at risk of developing diabetes-related complications such as heart disease, kidney failure, and hypoglycemia (low blood sugar) than younger people living with diabetes. Moreover, diabetes in older adults is a significant and growing public health problem across the globe. According to the WHO, by 2050, the world's population of people aged 60 years and older will double (2.1 billion).
Advent of artificial intelligence (AI) in diabetes management devices is expected to offer lucrative growth opportunities for players in the global digital diabetes management market. For instance, digital diabetes management devices are revolutionizing diabetes treatment with the introduction of AI in these devices.
Increasing demand for digital diabetes management devices is expected to offer significant growth opportunities for players in the global digital diabetes management market. For instance, there is an increasing demand for digital devices, such as smart insulin pens, smart insulin pumps, smart glucose meter, and/or continuous blood glucose monitoring devices worldwide.
With technologies such as AI, diabetes care devices can play a vital role in managing this chronic disease. For instance, smart insulin pens can transmit dosing data with Bluetooth Technology and allow programming of carbohydrate ratios and sensitivity factors, simplifying the management for clinicians. Technological advancements or technologies like these make it easier to manage people with diabetes more carefully and increase the demand or adoption of such devices worldwide. This trend is expected to continue during the forecast period.
Government initiatives to promote awareness about diabetes and user-friendly interfaces of insulin delivery devices are driving the demand for digital diabetes management devices in the homecare settings. Growing awareness about technologically advanced products is responsible for the higher adoption of these devices worldwide. Moreover, considerable rise in diabetes burden and several government awareness programs may propel the growth of the market. This trend is also expected to continue over the forecast period, driving the market growth.
*Definition: Digital diabetes management devices, like smart insulin pens, smart insulin pumps, smart glucose meter, and continuous blood glucose monitoring devices, help people with diabetes (type I and type II) to monitor and manage their glucose levels.
Share
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
